Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302

被引：0
|
作者：
Yosuke Kawashima
Toshiyuki Harada
Yuka Fujita
Taku Nakagawa
Kana Watanabe
Naoto Morikawa
Kei Takamura
Kenya Kanazawa
Tomoya Kuda
Kazuhiro Usui
Akimasa Sekine
Akira Inoue
Shunichi Sugawara
机构：
[1] Sendai Kousei Hospital,Department of Pulmonary Medicine
[2] JCHO Hokkaido Hospital,Department of Respiratory Medicine
[3] National Hospital Organization Asahikawa Medical Center,Department of Respiratory Medicine
[4] Omagari Kosei Medical Center,Department of Thoracic Surgery
[5] Miyagi Cancer Center,Department of Respiratory Medicine
[6] Iwate Medical University School of Medicine,Division of Pulmonary Medicine, Allergy, and Rheumatology
[7] Obihiro Kosei Hospital,Department of Pulmonary Medicine
[8] Fukushima Medical University School of Medicine,Department of Pulmonary Medicine
[9] Naha City Hospital,Department of Respiratory Medicine
[10] NTT Medical Center Tokyo,Division of Respirology
[11] Kanagawa Cardiovascular and Respiratory Center,Department of Respiratory Medicine
[12] Tohoku University School of Medicine,Department of Palliative Medicine
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Carboplatin; Albumin-bound paclitaxel; Cisplatin; Gemcitabine; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：515 / 522
页数：7
相关论文
共 50 条
  • [1] Randomized phase II trial of carboplatin plus nab-paclitaxel versus cisplatin plus gemcitabine for chemotherapy-naive squamous cell carcinoma: North Japan lung cancer study group 1302
    Kawashima, Yosuke
    Harada, Toshiyuki
    Fujita, Yuka
    Nakagawa, Taku
    Watanabe, Kana
    Morikawa, Naoto
    Takamura, Kei
    Kanazawa, Kenya
    Kuda, Tomoya
    Usui, Kazuhiro
    Sekine, Akimasa
    Inoue, Akira
    Sugawara, Shunichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (03) : 515 - 522
  • [2] A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer
    Yoshihiro Hattori
    Yuko Kono
    Shoichi Itoh
    Takako Inoue
    Yoshiko Urata
    Yoshitaka Kawa
    Rie Tohnai
    Toru Kumagai
    Kazumi Nishino
    Ryuji Uozumi
    Satoshi Morita
    Shunichi Negoro
    Fumio Imamura
    Miyako Satouchi
    BMC Cancer, 20
  • [3] Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non–small cell lung cancer
    Isamu Okamoto
    Nobuyuki Yamamoto
    Kaoru Kubota
    Yuichiro Ohe
    Naoyuki Nogami
    Haruyasu Murakami
    Hidetoshi Yamaya
    Katsuhiro Ono
    Kazuhiko Nakagawa
    Investigational New Drugs, 2012, 30 : 1132 - 1137
  • [4] A phase II trial of first-line nab-paclitaxel/carboplatin versus gemcitabine/carboplatin in advanced squamous cell carcinoma of the lung (CTONG1002)
    Yang, Jinji
    Huang, Cheng
    Song, Yong
    Cheng, Ying
    Chen, Gongyan
    Yan, Hong-Hong
    Zhou, Qing
    Chen, Huajun
    Ben, Xiao-song
    Wu, Yi-Long
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung
    Yang, Jin-Ji
    Huang, Cheng
    Chen, Gong-Yan
    Song, Yong
    Cheng, Ying
    Yan, Hong-Hong
    Zhou, Qing
    Wu, Yi-Long
    BMC CANCER, 2014, 14
  • [6] A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung
    Jin-Ji Yang
    Cheng Huang
    Gong-Yan Chen
    Yong Song
    Ying Cheng
    Hong-Hong Yan
    Qing Zhou
    Yi-Long Wu
    BMC Cancer, 14
  • [7] Phase II Study of Carboplatin plus Weekly Nab-Paclitaxel in Elderly Patients with NSCLC: North Japan Lung Cancer Study Group Trial 1301
    Ishimoto, Osamu
    Usui, Kazuhiro
    Maemondo, Makoto
    Miyauchi, Eisaku
    Saito, Heisuke
    Fujita, Yuka
    Kato, Terufumi
    Suzuki, Toshiro
    Nakagawa, Taku
    Harada, Toshiyuki
    Miura, Hiroyuki
    Watanabe, Hiroshi
    Inoue, Akira
    Ichinose, Masakazu
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S657 - S658
  • [8] Biomarker Analyses from a Phase II Trial of Nab-Paclitaxel/Carboplatin vs Emcitabine/Carboplatin in Advanced Squamous Cell Lung Cancer
    Yang, Jin-Ji
    Ben, Xiao-Song
    Huang, Cheng
    Song, Yong
    Cheng, Ying
    Chen, Gongyan
    Yan, Hong-Hong
    Zhou, Qing
    Chen, Hua-Jun
    Zhang, Xu-Chao
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S656 - S656
  • [9] Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301
    Miyauchi, Eisaku
    Inoue, Akira
    Usui, Kazuhiro
    Sugawara, Shunichi
    Maemondo, Makoto
    Saito, Heisuke
    Fujita, Yuka
    Kato, Terufumi
    Suzuki, Toshiro
    Harada, Toshiyuki
    Watanabe, Hiroshi
    Nakagawa, Taku
    Ichinose, Masakazu
    ONCOLOGIST, 2017, 22 (06): : 640 - +
  • [10] Carboplatin plus nab-paclitaxel for recurrent small cell lung cancer: A phase II study
    Ikeda, Naoya
    Arai, Ryo
    Soda, Sayo
    Inoue, Takashi
    Uchida, Nobuhiko
    Nakamura, Yusuke
    Masawa, Meitetsu
    Kushima, Yoshitomo
    Okutomi, Hiroaki
    Takemasa, Akihiro
    Shimizu, Yasuo
    Niho, Seiji
    THORACIC CANCER, 2022, 13 (09) : 1342 - 1348
12345